{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:51:01Z","timestamp":1768294261722,"version":"3.49.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.prro.2024.05.004","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T21:15:45Z","timestamp":1716930945000},"page":"e487-e491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stereotactic Body Radiation Therapy for Oligoprogressive Pleural Mesothelioma: Fine-Tuning the Optimal Doses"],"prefix":"10.1016","volume":"14","author":[{"given":"Paolo","family":"Ghirardelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Guaineri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Vavassori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8599-0629","authenticated-orcid":false,"given":"Giovanni Luca","family":"Ceresoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2024.05.004_bib0001","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3389\/fonc.2019.00961","article-title":"Stereotactic body radiation therapy (SBRT) as salvage therapy for oligorecurrent pleural mesothelioma after multi-modality therapy","volume":"9","author":"Schr\u00f6der","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2024.05.004_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2020.11.022","article-title":"Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma","volume":"152","author":"Ghirardelli","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prro.2024.05.004_bib0003","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.lungcan.2021.02.033","article-title":"Managing oligoprogressive malignant pleural mesothelioma with stereotactic body radiation therapy","volume":"157","author":"Barsky","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prro.2024.05.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110057","article-title":"Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma","volume":"191","author":"Shin","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.004_bib0005","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jtho.2018.04.034","article-title":"Revised modified response evaluation criteria in solid tumors for assessment of response in malignant pleural mesothelioma (version 1.1)","volume":"13","author":"Armato","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.prro.2024.05.004_bib0006","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lungcan.2021.05.001","article-title":"A reply to \u201cmanaging oligoprogressive malignant pleural mesothelioma with stereotactic body radiation therapy\u201d","volume":"157","author":"Ceresoli","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prro.2024.05.004_bib0007","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0360-3016(98)00409-X","article-title":"Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura\u2013a single-institution experience with 189 patients","volume":"43","author":"de Graaf-Strukowska","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.004_bib0008","article-title":"A phase 1 safety study of avelumab plus stereotactic body radiation therapy in malignant pleural mesothelioma","volume":"4","author":"Rimner","year":"2022","journal-title":"JTO Clin Res Rep"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187985002400136X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187985002400136X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T12:28:43Z","timestamp":1746188923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187985002400136X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S187985002400136X"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2024.05.004","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Body Radiation Therapy for Oligoprogressive Pleural Mesothelioma: Fine-Tuning the Optimal Doses","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2024.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}